Targeting phosphatidylserine signaling as a new cancer immunotherapy

Dayoub and Brekken “TIMs, TAMs, and PS-Antibody Targeting: Implications for Cancer Immunotherapy.” Cell Communication and Signaling (2020)

Read the article: https://doi.org/10.1186/s12964-020-0521-5

Video produced by www.researchsquare.com/researchers/videos

source